Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1984-12-05
1987-06-23
Hollrah, Glennon H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548251, 548253, A61K 3141, C07D25704
Patent
active
046753338
ABSTRACT:
There are described compounds of the formula ##STR1## in which R.sup.1 is hydrogen or C.sub.1-6 alkyl, R.sup.2 is hydrogen, C.sub.1-6 alkyl or C.sub.3-6 alkenyl, R.sup.3 is hydrogen or C.sub.1-6 alkyl, R.sup.4 is hydrogen or an N-protecting group, n is 2, 3, 4 or 5, and X is oxygen, sulphur or --CH.sub.2 --, provided that when X is --CH.sub.2 -- n is 0; and salts thereof. The compounds in which R.sup.4 is hydrogen have pharmaceutical activity.
REFERENCES:
patent: 4595570 (1986-01-01), Goldsworthy
Steggles David J.
Verge John P.
Conrad Robert A.
Hollrah Glennon H.
Lilly Industries Limited
Springer D. B.
Whitaker Leroy
LandOfFree
N-[4-[.omega.-(4-acyl-3-hydroxyphenoxy)alkoxy]-p henyl]1H-tetraz does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-[4-[.omega.-(4-acyl-3-hydroxyphenoxy)alkoxy]-p henyl]1H-tetraz, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-[4-[.omega.-(4-acyl-3-hydroxyphenoxy)alkoxy]-p henyl]1H-tetraz will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-721483